Overview

Research on New Regimens for Retreatment Pulmonary Tuberculosis

Status:
Unknown status
Trial end date:
2016-12-01
Target enrollment:
Participant gender:
Summary
Multi-center, prospective study is performed to investigate the efficacy of new short-course regimen for retreatment pulmonary tuberculosis patients. To obtain optimized short-course regimen, decrease treatment cost and improve success rate.
Phase:
Phase 4
Details
Lead Sponsor:
Shanghai Pulmonary Hospital, Shanghai, China
Collaborators:
Centers for Disease Control and Prevention
Jiangsu Province Centers for Disease Control and Prevention
Shanghai Center for Disease Control and Prevention
Zhejiang University
Treatments:
Ethambutol
Isoniazid
Moxifloxacin
Norgestimate, ethinyl estradiol drug combination
Pyrazinamide
Rifabutin
Rifampin
Streptomycin